Shattuck Labs Inc. STTK
$4.42
▲ +18.18% 24H
About
Shattuck Labs Inc. is a biopharmaceutical company focused on developing novel biologic therapies for cancer and autoimmune diseases. The company's proprietary platform, known as Agonist Redirected Checkpoint (ARC), is designed to harness the immune system's power to fight diseases by engaging both T cells and antigen-p…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees40
TickerSTTK
Statistics
Market Cap$334.1M
Revenue (TTM)$1.0M
Net Income-$48.8M
Net Margin-4880.9%
EPS$-0.70
P/E-7.06
P/S320.52
P/B3.30
EV/EBITDA-4.68
ROE-61.0%
Dividend Yield—
Price$4.42
Data: Twelve Data · Revenue = mcap / P/S